United States of America v. Carlos Sacanell

Philadelphia, Pennsylvania, criminal defense lawyer represented the Defendant charged with insider trading.

Carlos Sacanell, 59, of Willow Grove, Pennsylvania, was charged by indictment in October 2024. In September of last year, he pleaded guilty to one count of securities fraud (insider trading) and one count of making a false statement to a federal agency.

As detailed in court filings and admitted to by the defendant, Sacanell obtained material nonpublic information from his domestic partner, who was an executive at Oak Street Health, about CVS Health Corporation’s acquisition of Oak Street Health in 2023. At all times relevant to this matter, both CVS and Oak Street Health were publicly traded companies on the New York Stock Exchange, with ticker symbols CVS and OSH, respectively.

Sacanell used the material nonpublic information obtained from his domestic partner to trade stock and options in Oak Street Health before the transaction was publicly announced on February 8, 2023, resulting in him obtaining profits of approximately $617,000.

When the defendant was interviewed by the FBI in April 2024, he falsely told agents that he did not obtain from his domestic partner information regarding CVS’s planned acquisition of Oak Street Health before the acquisition was publicly announced on February 8, 2023.

This case was investigated by the FBI and prosecuted by Assistant United States Attorney Francis A. Weber. The Securities and Exchange Commission also charged Sacanell, in a parallel matter.

The Defendant was found guilty and was sentenced to 24 months’ imprisonment and a $5000 fine.